Dedicated to Finding New Medicines by Targeting the Ubiquitin Proteasome System and PROTAC®s

Progenra’s mission is to leverage its expertise in the ubiquitin proteasome system and cellular protein regulation, acquired over several years, to discover and develop novel, first in class medicines to fill unmet needs in a spectrum of therapeutic areas.

PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.